
Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing. Cormorant Asset Management led the round.
Source: Press Release
Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing.
Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing. Cormorant Asset Management led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination